Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1468)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (54)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (55)
¹ÙÀÌ¿ÀÀåºñ (323)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (53)
À¯ÀüÀÚ Ä¡·á/RNAi (100)
Àç»ýÀÇÇÐ (125)
Ç×ü/¸é¿ª (187)
Áö¿ªº°°Ë»ö
ÃâÆÇ»ç¿¡¼­ ã±â

¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÁ¶»çº¸°í¼­

¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå ±Ô¸ð, »ê¾÷ ºÐ¼®, ÇâÈÄ ½ÃÀå ¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
º¸°í¼­¿¡ µû¶ó¼­ ÁÖ¿ä ±â¾÷ ºÐ¼®, °æÀïȯ°æ ºÐ¼®, ¿¬±¸°³¹ß ÇöȲ, ¿µ¾÷ Àü·«, ±â¾÷ Á¦ÈÞ ÇöȲÀ» Æ÷ÇÔÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

»ó¼¼ºÐ·ù
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 154 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
Biomarker Partnering Terms and Agreements
»ùÇÃ
»óǰÄÚµå :229876
¹ÙÀÌ¿À ÀǾàǰ ¾÷°è¿¡¼­ÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °Å·¡ ±¸Á¶, ½ÇÁ¦ °Å·¡ »ç·Ê ¿¬±¸, 2007³â ÀÌÈÄÀÇ °Å·¡ µ¿ÇâÀ» Á¶»çÇßÀ¸¸ç, 550°³ ÀÌ»ó °è¾à ¹®¼­¿¡ ´ëÇÑ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,695
¹ßÇàÀÏ 2012³â 02¿ù
¸®¼­Ä¡»ç Current Partnering, a division of Wildwood Ventures Limited
ÆäÀÌÁö¼ö  
Biochips - technologies,markets and companies
»óǰÄÚµå :136243
¹ÙÀÌ¿ÀĨ(Biochip) ¹× ¸¶ÀÌÅ©·Î¾î·¹ÀÌ(Microarrays) ½ÃÀåÀ» Á¶»çÇϰí, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, ´Ù¾çÇÏ ±â¼ú ÀÀ¿ë ºÐ¾ß, ½ÃÀå¿¡ ÁøÃâÇÑ ±â¾÷ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,400
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
Cytogenetics - technologies,markets and companies
»óǰÄÚµå :70938
¿°»öü ±¸Á¶ÀÇ ¼ö½Ä ¹× Áúȯ¿¡ °ü·ÃµÈ ÀÌ»óÀ» ƯÁ¤ÇÏ´Â ¼¼Æ÷À¯ÀüÇÐ(Cytogenetics)¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
Biomarkers - technologies,markets and companies
»óǰÄÚµå :70937
´Ù¾çÇÑ Á¾·ùÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °³¿ä, ¹ÙÀÌ¿À¸¶Ä¿ ¹ßÀüÀ» À§ÇÑ °¢Á¾ ±â¼ú, °¢Á¾ Áúº´ ºÐ¾ß¿¡¼­ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¿ªÇÒ µîÀ» Á¶»ç ºÐ¼®ÇÏ°í ±ÔÁ¦»óÀÇ °úÁ¦, ¹ÌÃÑÁ· ¿ä°Ç, ½ÃÀ强Àå ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,000
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
Molecular Diagnostics - Technologies, Markets and Companies
»óǰÄÚµå :70915
ÀÇ·áȰµ¿, °øÁßÀ§»ý, ÀǾàǰ »ê¾÷, ¹ýÀÇÇÐ µî¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÏ´Â ºÐÀÚÁø´Ü ±â¼ú¿¡ ´ëÇØ Á¶»çÇϰí, °¢Á¾ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ±â¹Ý ±â¼ú, Çü±¤µ¿¼Ò±³Àâ¹ý(FISH), ÆéŸÀ̵åÇÙ»ê(PNA), DNAÀÇ Àü±âÈ­ÇаËÃâ, ¹ÙÀÌ¿ÀĨ, ³ª³ëÅ×Å©³î·¯Áö ¹× ÇÁ·ÎÅ׿À¹Í½º ±â¼ú¿¡ °üÇÑ ºÐ¼® µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,500
¹ßÇàÀÏ 2012³â 01¿ù
¸®¼­Ä¡»ç Jain Pharmabiotech
ÆäÀÌÁö¼ö  
European Molecular Diagnostics Markets
»ùÇÃ
»óǰÄÚµå :227473
À¯·´ ºÐÀÚ Áø´Ü ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ÀÇ·á ºÎ¹® ¹× ÁÖ¿ä Áö¿ª/±¹°¡º° ½ÃÀå ºÐ¼®, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÀúÇØ¿äÀÎ, ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®, °æÀï ȯ°æ, ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 6,000
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Frost & Sullivan
ÆäÀÌÁö¼ö  
World Molecular Diagnostics Market: Growth Opportunities, Business Expansion Strategies, Entry Barriers and Risks
»ùÇÃ
»óǰÄÚµå :225055
¼¼°è ºÐÀÚÁø´Ü(Molecular Diagnostics) °ü·Ã ½ÃÀåÀÇ ½ÅÁ¦Ç°(Áø´Ü Àåºñ, ¼Ò¸ðǰ, º¸Á¶ Á¦Ç°) °³¹ß ±âȸ¿¡ ´ëÇØ ºÐ¼®Çϰí, ÃÑ 60°³ ǰ¸ñ ÀÌ»óÀÇ Á¦Ç°¿¡ ´ëÇØ ÀÌ»óÀûÀÎ Á¦Ç° ¸ðµ¨(¿¹Ãø °¡°Ý, °Ë»ç Ư¼º µîÀÇ Á¤º¸ Æ÷ÇÔ)À» Á¦½ÃÇØ µå¸®¸ç, °ø±Þ¾÷ü¸¦ À§ÇÑ ´ëüÀû Á¦Ç° º¸±Þ Àü·« Á¦¾È µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Molecular Diagnostic Applications: Forensics, Paternity, Disease Susceptibility
»ùÇÃ
»óǰÄÚµå :225054
¹ýÀÇÇÐ °Ë»ç, Ä£ÀÚ°¨º°, À̺´¼º ¹× ±âŸ ºÐÀÚ Áø´Ü °Ë»ç µî ÁÖ¿ä ºÐÀÚ Áø´Ü °Ë»çÀÇ ÀÓ»óÀû À¯ÀǼº°ú ½ÃÀåÀÇ ¼ö¿ä¿¡ ´ëÇØ °ËÁõÇϰí, ºÐÀÚ Áø´ÜÀÇ ½Å±â¼ú°ú ½ÅÁ¦Ç°À» °³¹ß/ÆÇ¸ÅÇϰí ÀÖ´Â ±â¾÷ ¸®½ºÆ®¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
World Molecular Diagnostics Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
»ùÇÃ
»óǰÄÚµå :225053
¼¼°è ºÐÀÚÁø´Ü(Molecular Diagnostics) ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ¹× ½ÅÈï±â¾÷ÀÇ Àü·«À» Æò°¡ÇÏ¿© ±× °á°ú¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 2,500
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Emerging Cancer Molecular Diagnostic Tests
»ùÇÃ
»óǰÄÚµå :225052
ÁÖ¿ä Á¾¾ç ¸¶Ä¿ÀÇ ÀÓ»óÀû ÀÇÀÇ, ½ÃÀå ¿ä±¸ °³¿ä, ¾Ï °Ë»ç ºÐÀÚÁø´Ü(Molecular Diagnostic) ±â¼ú, Á¦Ç° °³¹ß ¹× ¸¶ÄÉÆÃ ±â¾÷ °³¿ä¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,450
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
World Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country
»ùÇÃ
»óǰÄÚµå :225051
¼¼°è °¢±¹ÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics) ½ÃÀåÀ» ºÐ¼®Çϰí, DNA ¿°±â¹è¿­ °áÁ¤ ¹× ºÐÀÚÁø´Ü °Ë»ç¸¦ ½Ç½ÃÇϰí ÀÖ´Â ½Ã¼³ ¿¹Ãø, ÇâÈÄ 5-10³â°£ÀÇ °Ë»ç °Ç¼ö, Áø´Ü ¸ÅÃâ ¿¹Ãø Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,850
¹ßÇàÀÏ 2011³â 12¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Innovations in Molecular Diagnostics for Infectious Diseases
»ùÇÃ
»óǰÄÚµå :228156
½Å»ý ¹× º¯ÀÌ º´¿øÃ¼ ¹× »õ·Î¿î ºÐÀÚ ½ÃÇè ±â¼úÀ» ÀÇ·á °ü·Ã °¨¿°(ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º °¨¿°, Ç÷¾× ¸Å°³ ¹ÙÀÌ·¯½º °¨¿°, È£Èí±â ¹ÙÀÌ·¯½º °¨¿° µî) ºÐ¾ßÀÇ ¿ì¼öÇÑ Áø´Ü Á¦Ç°¿¡ °áÇÕ½ÃŰ´Â ¹æ¹ýÀÌ µîÀåÇÏ°Ô µÇ¸é¼­, ºÐÀÚ Áø´Ü ±â¼ú°³¹ßÀÚ¿¡°Ô ÁÖ¾îÁö´Â ±âȸ¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,835
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Business Insights
ÆäÀÌÁö¼ö Pages: 168
Future US Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224815
¹Ì±¹ÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, ¹Ì±¹ ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 8,400
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future UK Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224814
¿µ±¹ÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, ¿µ±¹ ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future Spanish Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224813
½ºÆäÀÎÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, ½ºÆäÀÎ ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future Japanese Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224812
ÀϺ»ÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, ÀϺ» ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 7,500
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future Italian Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224811
ÀÌÅ»¸®¾ÆÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, ÀÌÅ»¸®¾Æ ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future German Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224810
µ¶ÀÏÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, µ¶ÀÏ ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Future French Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
»ùÇÃ
»óǰÄÚµå :224809
ÇÁ¶û½ºÀÇ ºÐÀÚÁø´Ü(Molecular Diagnostics)½ÃÀå Ãֽе¿Çâ°ú ÇâÈÄ Àü¸ÁÀ» ºÐ¼®Çϰí, Áø´Ü ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, ¼¼°è ½ÃÀå °³¿ä, ÇÁ¶û½º ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 10³â°£ µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 5,900
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Venture Planning Group
ÆäÀÌÁö¼ö  
Global Cardiac Markers Device Market 2010-2014
»ùÇÃ
»óǰÄÚµå :222971
2010³âºÎÅÍ 2014³â±îÁö ¼¼°è ½ÉÀå ¸¶Ä¿ ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå±Ô¸ð¿Í ¿¹Ãø, ½ÃÀå ¼ºÀå¿äÀΰú °úÁ¦, ÁÖ¿ä º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,500
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Infiniti Research Limited
ÆäÀÌÁö¼ö Pages: 28
Cardiac Marker Diagnostic Testing Markets
»ùÇÃ
»óǰÄÚµå :220781
½ÉÀå ¸¶Ä¿(Cardiac Marker) °Ë»ç¸¦ À§ÇÑ Ã¼¿Ü Áø´Ü(IVD) ½ÃÀåÀ» ºÐ¼®Çϰí, º´¿ø ¹× Ŭ¸®´Ð¿¡¼­ ÀÌ¿ëµÇ´Â ÀÓ»ó ÃøÁ¤ Àåºñ¿Í ½Ã¾à, ºñǰ ¹× ½ÉÀå ¸¶Ä¿ Áø´Ü °Ë»çÀÇ ÇâÈÄ ¹ßÀü ¿¹Ãø µîÀ» ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,400
¹ßÇàÀÏ 2011³â 11¿ù
¸®¼­Ä¡»ç Trimark Publications
ÆäÀÌÁö¼ö 139 Pages
VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011
»ùÇÃ
»óǰÄÚµå :218352
VEGF ¾ïÁ¦(Inhibition) °³¿ä¿Í ¿¹ÈÄ ¹ÙÀÌ¿À¸¶Ä¿(Prognostic Biomarker)¿¡ ´ëÇØ ´Ù¾çÇÑ ¾Ï Á¾·ùº° ¹ÙÀÌ¿À¸¶Ä¿ È常¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 1,520
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç BioPharm Reports (Technology and Markets Ltd)
ÆäÀÌÁö¼ö 97 Pages
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
»ùÇÃ
»óǰÄÚµå :216699
¼¼°è Drug DiscoveryÀÇ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå µ¿Çâ°ú ±â¼ú µµÀÔ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï µ¿Çâ, ¹ý±ÔÁ¦ µ¿Çâ, °¢ ±â¾÷ÀÇ °³¿ä¿Í ÆÄÀÌÇÁ¶óÀÎÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,500
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç GBI Research
ÆäÀÌÁö¼ö Pages: 103
»ùÇÃ
»óǰÄÚµå :225214
¼¼°èÀÇ ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀ» ºÐ¼®ÇßÀ¸¸ç, ¹Ì±¹, À¯·´ ºÎ¹®º° ½ÃÀå µ¿Çâ, 2009¡­2017³â ¿¹Ãø, ½ÃÀå¿¡ Âü¿©ÇÑ ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 4,500
¹ßÇàÀÏ 2011³â 10¿ù
¸®¼­Ä¡»ç Global Industry Analysts, Inc.
ÆäÀÌÁö¼ö Pages: 444
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
»ùÇÃ
»óǰÄÚµå :214200
¹ÙÀÌ¿À¸¶Ä¿ ±â¼ú(Biomarker Technology) µ¿Çâ°ú »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿¿¡ ÀÇÇÑ Áø´Ü ±â¼ú, ½ÃÀå ±âȸ¿Í ¼¼°èÀÇ ¸ÅÃâ µ¿Ç⠵ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
... ´õº¸±â
°¡°Ý US $ 3,400
¹ßÇàÀÏ 2011³â 09¿ù
¸®¼­Ä¡»ç Trimark Publications
ÆäÀÌÁö¼ö 342 Pages